Alex Lobo | Stern Investor Relations |
Milton Werner | President & Chief Executive Officer |
Joe Frattaroli | Chief Financial Officer |
Good morning and welcome to the Inhibikase Fourth Quarter and Full Year 2022 Earnings Conference Call. [Operator Instructions] Please note, today's event is being recorded.
I would now like to turn the conference over to Alex Lobo with Stern IR. Please go ahead.
Good morning and welcome to Inhibikase Therapeutics fourth quarter and full year 2022 financial results conference call and audio webcast.